UNH Surges 38.6% as Earnings Beats Erase Last Year's Damage

UnitedHealth Group's (UNH) stock price has surged by 38.6% since early March, reaching $401 as of September 3. This significant increase is largely attributed to two consecutive quarters of earnings beats, which have helped erase the damage from last year's guidance cuts.

The company reported first-quarter adjusted earnings of $7.23 a share, exceeding estimates and boosting its full-year outlook. The second-quarter results also showed improved earnings quality, with management citing a durable underlying run rate as support for the new number.

UnitedHealthcare will drop prior authorization requirements on a broad range of services starting October 1, part of a plan to cut prior authorization volume by 30% by year-end. This move is seen as an operational thread beyond the earnings comps and reinforces management's commitment to rebuilding trust with regulators and providers.

Analysts have been playing catch-up, raising their price targets in response to UNH's strong performance. The current mean target sits at $475, 19% above the current price, indicating a potential upside of nearly 20%. However, TIKR's mid-case model values UNH stock at $722 by December 2030, implying an 80% total return and 15% annualized over 4.3 years.